JP2007528222A5 - - Google Patents

Download PDF

Info

Publication number
JP2007528222A5
JP2007528222A5 JP2007502440A JP2007502440A JP2007528222A5 JP 2007528222 A5 JP2007528222 A5 JP 2007528222A5 JP 2007502440 A JP2007502440 A JP 2007502440A JP 2007502440 A JP2007502440 A JP 2007502440A JP 2007528222 A5 JP2007528222 A5 JP 2007528222A5
Authority
JP
Japan
Prior art keywords
cells
composition
culture
vivo
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007502440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007528222A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2005/001072 external-priority patent/WO2005085424A2/en
Publication of JP2007528222A publication Critical patent/JP2007528222A/ja
Publication of JP2007528222A5 publication Critical patent/JP2007528222A5/ja
Pending legal-status Critical Current

Links

JP2007502440A 2004-03-09 2005-03-09 内皮前駆細胞およびその使用方法 Pending JP2007528222A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55159404P 2004-03-09 2004-03-09
PCT/IB2005/001072 WO2005085424A2 (en) 2004-03-09 2005-03-09 Endothelial progenitor cells and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012164885A Division JP2012210227A (ja) 2004-03-09 2012-07-25 内皮前駆細胞およびその使用方法

Publications (2)

Publication Number Publication Date
JP2007528222A JP2007528222A (ja) 2007-10-11
JP2007528222A5 true JP2007528222A5 (https=) 2008-04-24

Family

ID=34919593

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007502440A Pending JP2007528222A (ja) 2004-03-09 2005-03-09 内皮前駆細胞およびその使用方法
JP2012164885A Pending JP2012210227A (ja) 2004-03-09 2012-07-25 内皮前駆細胞およびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012164885A Pending JP2012210227A (ja) 2004-03-09 2012-07-25 内皮前駆細胞およびその使用方法

Country Status (8)

Country Link
US (2) US20050201990A1 (https=)
EP (1) EP1737949B1 (https=)
JP (2) JP2007528222A (https=)
AT (1) ATE481477T1 (https=)
AU (1) AU2005219660B2 (https=)
CA (1) CA2559110A1 (https=)
DE (1) DE602005023592D1 (https=)
WO (1) WO2005085424A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE481477T1 (de) * 2004-03-09 2010-10-15 Absorber Ab Endothelvorläuferzellen und verfahren zur verwendung davon
AU2008223817A1 (en) * 2007-03-02 2008-09-12 National University Of Ireland, Galway Osteopontin for the prediction and treatment of cardiovascular diseases
ES2689932T3 (es) * 2008-11-04 2018-11-16 Inregen Construcciones de armazones de células
EP2198873A1 (en) * 2008-12-18 2010-06-23 Aposcience AG Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
EP2201954A1 (en) * 2008-12-18 2010-06-30 Aposcience AG Pharmaceutical preparation
US20120233218A1 (en) * 2011-03-09 2012-09-13 Christopher Liam Ivey System and Method for Delivering Brand Reinforcement as a Component of a Human Interactive Proof
US20120295347A1 (en) * 2011-05-20 2012-11-22 Steven Kessler Methods and Compositions for Producing Endothelial Progenitor Cells from Pluripotent Stem Cells
WO2014197421A1 (en) 2013-06-05 2014-12-11 Biotime, Inc. Compositions and methods for induced tissue regeneration in mammalian species
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
CN106699885B (zh) * 2015-11-18 2020-03-24 北京步长新药研发有限公司 一种人源抗vegfr2抗体及其应用
CA3202332A1 (en) 2015-12-07 2017-06-15 Agex Therapeutics, Inc. Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
NO155316C (no) * 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US5130144B1 (en) * 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5026365A (en) * 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
ATE81724T1 (de) * 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5283187A (en) * 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5071741A (en) * 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
DE3829752A1 (de) * 1988-09-01 1990-03-22 Akzo Gmbh Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
DE3829766A1 (de) * 1988-09-01 1990-03-22 Akzo Gmbh Verfahren zur herstellung von membranen
US5084350A (en) * 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
CA2109085C (en) * 1991-04-25 2003-03-11 Keith E. Dionne Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US5955291A (en) * 1992-01-09 1999-09-21 Alitalo; Kari Antibodies recognizing tie receptor tyrosine kinase and uses thereof
BR9306040A (pt) * 1992-03-06 1997-11-18 Statens Seruminstitut Tratamento e profilaxia de doenças provocadas por parasitos ou bactérias
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US6060643A (en) * 1995-08-04 2000-05-09 Emory University Mouse model with human immune system
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
US20030125615A1 (en) * 1998-02-05 2003-07-03 Yitzhack Schwartz Homing of autologous cells to a target zone in tissue using active therapeutics or substances
US20030100107A1 (en) * 1998-05-29 2003-05-29 Thomas Jefferson University Compositions and methods for generating differentiated human cells
US20020150876A1 (en) * 2000-03-30 2002-10-17 Pippig Susanne Dagmar Selectable marker genes
GB0015923D0 (en) * 2000-06-30 2000-08-23 Astrazeneca Ab Methods
ATE481477T1 (de) * 2004-03-09 2010-10-15 Absorber Ab Endothelvorläuferzellen und verfahren zur verwendung davon

Similar Documents

Publication Publication Date Title
DiMuzio et al. Tissue engineering applications to vascular bypass graft development: the use of adipose-derived stem cells
Iwata et al. Cell sheet engineering and its application for periodontal regeneration
Stoltz et al. Stem cells and regenerative medicine: myth or reality of the 21th century
Vija et al. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes
KR101557256B1 (ko) 세포 증식 방법 및 세포의 용도 및 치료를 위해 그 세포에 의해 제조되는 조절된 배지
JP6548714B2 (ja) 放射線照射または化学物質による傷害を治療するための方法
Ghoneim et al. From mesenchymal stromal/stem cells to insulin-producing cells: progress and challenges
Hong et al. Ex vivo adipose tissue engineering by human marrow stromal cell seeded gelatin sponge
Takaku et al. In vivo cell tracking by bioluminescence imaging after transplantation of bioengineered cell sheets to the knee joint
JP2007528222A5 (https=)
WO2013136184A4 (en) Bioengineered allogeneic blood vessel
Moran et al. Whole-organ bioengineering: current tales of modern alchemy
AU2014203616B2 (en) Mammary artery derived cells and methods of use in tissue repair and regeneration
JP6147419B2 (ja) 心臓内膜由来の成体幹細胞及びこれの製造方法
Semenov et al. Mesenchymal stem cells derived from Wharton’s jelly and their potential for cardio-vascular tissue engineering
JP2009517078A5 (https=)
JP7323919B2 (ja) 虚血性心疾患治療用細胞シート
US20170274021A1 (en) Method for preparing a biological tissue construct and use of autologous cells obtained specifically
JP2017222581A (ja) 肝臓組織再生用組成物
JP6501245B2 (ja) 真皮再建用テンプレート
Katari et al. Tissue engineering and regenerative medicine solutions for the abdominal organs
Batty Pig Induced Pluripotent Stem Cells as a Preclinical Model for Cardiovascular Tissue Engineering
Auger The LOEX perspective on the role of tissue engineering in regenerative medicine
Kiyan et al. Vascularization of iPSC-Kidney Organoids In Vitro Is Improved by Co-Culturing With Macrophages: FR-PO359
Li et al. Urine progenitor cells for potential application in renal tissue repair